BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng R, Tao L, Kwong JSW, Zhong C, Li C, Chen S, Sun Y, Zhang X, Shang H. Risk factors associated with the severity of adverse drug reactions by Xiyanping injection: A propensity score-matched analysis. J Ethnopharmacol 2020;250:112424. [PMID: 31765765 DOI: 10.1016/j.jep.2019.112424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Han Z, Wang J, Zhang K, Tang Q. The ethics of COVID-19 clinical trials: New considerations in a controversial area. Integr Med Res 2020;9:100425. [PMID: 32426222 DOI: 10.1016/j.imr.2020.100425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
2 Xia M, Guo Y, Li J, Ma H, Gao W, Wu X. Correlation analysis of physicochemical properties with anti-inflammatory activity of Andrographis paniculata (Burm.f.) Nees based on HPLC-DAD, colorimeter and multivariate statistics: A comprehensive quality evaluation strategy. J Pharm Biomed Anal 2022;210:114565. [PMID: 35033944 DOI: 10.1016/j.jpba.2021.114565] [Reference Citation Analysis]
3 Zhao ZH, Zhou Y, Li WH, Huang QS, Tang ZH, Li H. Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on "The Diagnosis and Treatment Program for Coronavirus Disease-2019" from Chinese Authority. Am J Chin Med 2020;48:1035-49. [PMID: 32668970 DOI: 10.1142/S0192415X20500500] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
4 Zhu XB, Guo M, Zhang ZH, Sun LH, Liu L, Zhou LJ, Shan CL, Yang Y, Kan LD, Li LC. Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review. Integr Med Res 2021;10:100778. [PMID: 34608432 DOI: 10.1016/j.imr.2021.100778] [Reference Citation Analysis]